In addition, SREBP1c expression is also elevated in patients with NAFLD; additionally, in concordance with its lipogenic role, hepatic triglyceride levels are higher in SREBP1c-overexpressing transgenic mice26. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.